KAYAOĞLU, B. Et Al. 2021. Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation. JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.4 , 769-779.

KAYAOĞLU, B., Kasap, N., Yilmaz, N. S., Charbonnier, L. M., Geckin, B., Akcay, A., ... Eltan, S. B.(2021). Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation. JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.4, 769-779.

KAYAOĞLU, BAŞAK Et Al. "Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation," JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.4, 769-779, 2021

KAYAOĞLU, BAŞAK Et Al. "Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation." JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.4, pp.769-779, 2021

KAYAOĞLU, B. Et Al. (2021) . "Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation." JOURNAL OF CLINICAL IMMUNOLOGY , vol.41, no.4, pp.769-779.

@article{article, author={BAŞAK KAYAOĞLU Et Al. }, title={Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation}, journal={JOURNAL OF CLINICAL IMMUNOLOGY}, year=2021, pages={769-779} }